2-aminopyrimidine has been researched along with Hepatocellular Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abakshonok, A; Anisovich, M; Beklemisheva, A; Ignatovich, Z; Kaniukov, E; Koroleva, E; Novik, K; Panina, L; Shumskaya, A | 1 |
| Awasthi, BP; Chaudhary, P; Guragain, D; Jee, JG; Jeong, BS; Kim, JA | 1 |
2 other study(ies) available for 2-aminopyrimidine and Hepatocellular Carcinoma
| Article | Year |
|---|---|
One-Step Synthesis of Magnetic Nanocomposite with Embedded Biologically Active Substance.
Topics: Apoptosis; Carcinoma, Hepatocellular; Ferric Compounds; Hep G2 Cells; Humans; Liver Neoplasms; Magnetite Nanoparticles; Nanocomposites; Pyrimidines | 2021 |
Synthesis and anti-hepatocellular carcinoma activity of aminopyridinol-sorafenib hybrids.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line; Cell Line, Tumor; Cell Proliferation; Chick Embryo; Drug Screening Assays, Antitumor; Humans; Liver Neoplasms; Molecular Docking Simulation; Protein Kinase Inhibitors; Pyrimidines; Sorafenib; Xenograft Model Antitumor Assays | 2021 |